| 33.5223 -0.338 (-1%) | 04-19 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 42.77  |
1-year : | 44.76 |
| Resists | First : | 36.62 |
Second : | 38.33 |
| Pivot price | 36.35 |
|||
| Supports | First : | 33.86 |
Second : | 28.17 |
| MAs | MA(5) : | 34.94 |
MA(20) : | 36.6 |
| MA(100) : | 35.9  |
MA(250) : | 34.19 |
|
| MACD | MACD : | -0.8 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 0 | D(3) : | 0 |
| RSI | RSI(14): 30.6 |
|||
| 52-week | High : | 39.75 | Low : | 25.65 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ BTEC ] has closed below the lower bollinger band by 3.3%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 34.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 34.69 - 35.02 | 35.02 - 35.22 |
| Low: | 33.14 - 33.58 | 33.58 - 33.85 |
| Close: | 33.36 - 34.07 | 34.07 - 34.5 |
Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies in the healthcare sector. It invests significantly in early-stage companies within the healthcare equipment and supplies, pharmaceuticals, biotechnology, and life sciences industries that are not yet consistently profitable.
Tue, 02 Apr 2024
7 Best-Performing Biotech ETFs for April 2024 - NerdWallet
Mon, 11 Mar 2024
5 Small Biotech ETFs to Watch (Updated 2024) - Investing News Network
Mon, 18 Jul 2022
ETF Odds & Ends: Matthews Asia Debuts ETFs - etf.com
Tue, 01 Jun 2021
Bottom Performing ETFs For May 2021 - ETF Focus on TheStreet: ETF research and Trade Ideas - TheStreet
Mon, 09 Sep 2019
Elanco Animal Health (ELAN) Stock Price, News & Analysis - MarketBeat
Tue, 02 Jul 2019
Karuna Therapeutics (KRTX) Stock Price, News & Analysis - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|